![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
University Hospital, Ghent Medtronic |
---|---|
Information provided by: | University Hospital, Ghent |
ClinicalTrials.gov Identifier: | NCT00431457 |
Patients will be prospectively randomized to 3 different treatment arms:
Twelve months after inclusion unblinding will occur. Patients in group 2 and 3 will have the option to choose between continuing neurostimulation treatment or resective surgery.
Study visits will occur every 3 months.
Condition | Intervention |
---|---|
Epilepsy |
Device: Implantation of an intracranial electrode |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study |
Official Title: | Prospective Randomized Controlled Study of Neurostimulation in the Medial Temporal Lobe for Patients With Medically Refractory Medial Temporal Lobe Epilepsy; Controlled Randomized Stimulation Versus Resection (CoRaStiR) |
Estimated Enrollment: | 45 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Kristl Vonck, MD | 0032(0)9/240.64.88 | kristl.vonck@UGent.be |
Belgium | |
University Hospital Ghent | Recruiting |
Ghent, Belgium, 9000 | |
Contact: Kristl Vonck, MD 0032(0)9/240.64.88 kristl.vonck@UGent.be | |
Principal Investigator: Kristl Vonck, MD |
Principal Investigator: | Paul Boon, MD, PhD | University Hospital, Ghent |
Study ID Numbers: | 2007/005 |
Study First Received: | February 2, 2007 |
Last Updated: | December 19, 2007 |
ClinicalTrials.gov Identifier: | NCT00431457 |
Health Authority: | Belgium: Institutional Review Board |
Epilepsy Central Nervous System Diseases Brain Diseases Epilepsy, Temporal Lobe |
Nervous System Diseases |